Steven Pfeiffer
Technik-/Wissenschafts-/F&E-Leiter bei ODONATE, INC.
Aktive Positionen von Steven Pfeiffer
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ODONATE, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2016 | - |
Karriereverlauf von Steven Pfeiffer
Ehemalige bekannte Positionen von Steven Pfeiffer
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Corporate Officer/Principal | 01.01.2015 | 01.01.2016 |
KYTHERA BIOPHARMACEUTICALS INC | Corporate Officer/Principal | 01.01.2011 | 01.01.2015 |
SAI Life Sciences Ltd.
SAI Life Sciences Ltd. Pharmaceuticals: MajorHealth Technology SAI Life Sciences Ltd. manufactures, develops, and discovers pharmaceutical drugs. The company was founded in 1999 and is headquartered in Hyderabad, India. | Corporate Officer/Principal | 01.01.2009 | 01.01.2010 |
GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01.01.2005 | 01.01.2009 |
Ausbildung von Steven Pfeiffer
University of California, Santa Barbara | Doctorate Degree |
California State University-East Bay | Masters Business Admin |
University of Arizona | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 7 |
Irland | 2 |
Indien | 2 |
Operativ
Corporate Officer/Principal | 4 |
Chief Tech/Sci/R&D Officer | 1 |
Doctorate Degree | 1 |
Sektoral
Health Technology | 6 |
Consumer Services | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
ODONATE, INC. | Health Technology |
GILEAD SCIENCES, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
Horizon Therapeutics Plc
Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland. | Health Technology |
Kythera Biopharmaceuticals LLC
Kythera Biopharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Kythera Biopharmaceuticals LLC operates as a clinical-stage biopharmaceutical company. It focuses on the discovery, development, and commercialization of novel prescription products for the aesthetic medicine market. The company was founded by Jay Edward Birnbaum, Amit D. Munshi, Nathaniel Eames David, and Keith R. Leonard, Jr. on June 3, 2004 and is headquartered in Westlake, CA. | Health Technology |
SAI Life Sciences Ltd.
SAI Life Sciences Ltd. Pharmaceuticals: MajorHealth Technology SAI Life Sciences Ltd. manufactures, develops, and discovers pharmaceutical drugs. The company was founded in 1999 and is headquartered in Hyderabad, India. | Health Technology |
- Börse
- Insiders
- Steven Pfeiffer
- Erfahrung